NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/03/2024
Back to search
Official data from USPTO
QIAGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
12/03/2024
Trademark type
Combined
Nice classes
5
Filing date
07/24/2017
Registration date
12/12/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2017-01-00
First use in commerce
2017-01-00
Drawing code
3
Owner type
99
Owner location
Hilden, DE
Examiner
MURRAY, TY
Current location
Historical data usage
Mark description
The mark consists of the word "QIAGEN" below three rows of five circles.
Holders and representatives
Holders
Qiagen GmbH
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical and veterinary medical purposesfor the preparation of samplesthe modification and manipulation of samples and for the markingseparationisolationpurification and reproduction and analysis of biopolymersnucleic acidsproteinsmacromolecules and biologically active substances; chemicalbiochemical and biotechnological productsreagents and solvents for medical use for the preparation of samplesthe modification and the manipulation of samples and for performing markingseparationisolationpurificationreproduction and analysis methods for biopolymersnucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes for the preparation of samplesthe modification and manipulation of samples and for markingseparationisolationpurificationreproduction and analysis of biopolymersnucleic acidsproteinsmacromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample material
Publications
History of USPTO decisions and trademark events.
17 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/03/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/20/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
06/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/11/2024
E815
TEAS SECTION 8 & 15 RECEIVED
12/06/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/12/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/26/2017
PUBO
PUBLISHED FOR OPPOSITION
09/26/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/15/2017
DOCK
ASSIGNED TO EXAMINER
08/15/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2017
NWAP
NEW APPLICATION ENTERED
07/27/2017
Continuous trademark protection
Get notified about every new filing that threatens QIAGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.